ライフサイエンスコーパス: spinal fusion

1 guinal hernia repair, knee arthroplasty, and spinal fusion).

2 g radiographic fusion in patients undergoing spinal fusion.

3 H occurs in a subset of children who undergo spinal fusion.

4 tance of anaerobic bacteria in SSI following spinal fusion.

5 erior, posterior, or both anterior/posterior spinal fusion.

6 One death occurred 10 days following spinal fusion.

7 siological dose of BMP-2 used clinically for spinal fusion.

8 cally at high levels throughout a developing spinal fusion.

9 of newly regenerated bone in a rat model of spinal fusion.

10 (BMPs) can reduce morbidity associated with spinal fusions.

11 EA (-$730; 95% CI, -$1367 to -$94; P = .03), spinal fusion (-$3253; 95% CI, -$3879 to -$2627; P < .00

12 insurance for orthopedic procedures, such as spinal fusion [4.3%; 95% CI, 3.4%-5.2%; P < .001] and kn

13 males, -4.2 per 100 000 persons in females), spinal fusion (-7.7 per 100 000 persons in males, -15.0

14 surgery with extensive osseous involvement (spinal fusion and craniofacial reconstruction).

15 (BMP2) and BMP7 are FDA approved to promote spinal fusion and fracture healing, respectively, and th

16 amiliar with the imaging features of typical spinal fusion and many of the complications seen in pati

17 There were two deaths (7%), one following spinal fusion and the other following appendectomy at an

18 d clinically to induce new bone formation in spinal fusions and long bone non-union fractures.

19 recombinant BMPs promote healing of bone in spinal fusions and, in some cases, of open fractures, bu

20 by sex, frequency of progression to complete spinal fusion, and association between hip arthritis and

21 robability of a refill for humerus fracture, spinal fusion, and tonsillectomy.

22 fracture repair, cholecystectomy, posterior spinal fusion, and tonsillectomy.

23 throplasty, knee arthroplasty, hysterectomy, spinal fusion, and vertebral discectomy) from January 20

24 3 hysterectomies, 3 vasectomies, and 1 each spinal fusion, appendectomy, eye enucleation, hernia rep

25 for the year 2006 among patients undergoing spinal fusion by BMP use status, no differences were see

26 Black adult patients (including angioplasty, spinal fusion, carotid endarterectomy, appendectomy, col

27 As rates of spinal fusion continue to increase, rates of complicatio

28 one (ADH) is elevated in patients undergoing spinal fusion, especially in those who have clinical evi

29 intervertebral discs from 38 patients during spinal fusion for chronic back pain.

30 terature regarding long-term follow-up after spinal fusion for patients with adolescent idiopathic sc

31 afting (CABG), carotid endarterectomy (CEA), spinal fusion, hip or knee arthroplasty, hysterectomy, o

32 crews affixed to titanium alloy rods) lumbar spinal fusion in addition to decompressive laminectomy i

33 For example, rate of spinal fusion in Black patients was 70.2% of the rate in

34 tors has important implications for surgical spinal fusions in humans.

35 Lumbar spinal fusion is a commonly performed procedure, and, de

36 morphogenetic protein (rhBMP-2) for clinical spinal fusion is hindered by safety issues associated wi

37 Spinal fusion is one of the most common procedures perfo

38 lone compared with lumbar decompression plus spinal fusion (MCID, 2-4.9 points).

39 ne regeneration, including a newly developed spinal fusion model.

40 protein was used in approximately 25% of all spinal fusions nationally in 2006, with use associated w

41 (72%) in patients admitted after surgery for spinal fusion or craniofacial reconstruction.

42 e in most of spine diseases, and traditional spinal fusion or discectomy usually injure adjacent segm

43 bone graft substitutes for either achieving spinal fusion or in the healing of critical-sized fractu

44 es the risk for postoperative infections for spinal fusion patients.

45 ates of use of BMP among patients undergoing spinal fusion procedures are examined along with complic

46 cohort study of 328,468 patients undergoing spinal fusion procedures from 2002-2006 identified from

47 In spinal fusion, rhBMP-2 has no proven clinical advantage

48 l interventions (eg, tendon lengthenings and spinal fusion), steroid use, and extent of respiratory s

49 are a serious complications of instrumented spinal fusion surgeries, carrying high morbidity and com

50 ominal hysterectomy, colon, laminectomy, and spinal fusion surgeries.

51 Risk factors associated with prone spinal fusion surgery and ischemic optic neuropathy iden

52 hemic optic neuropathy associated with prone spinal fusion surgery that are extrinsic to the patient

53 Given the recent advances in spinal fusion surgery, it is important that radiologists

54 t of pneumocephalus and pneumorrhachis after spinal fusion surgery.

55 ted with ischemic optic neuropathy and prone spinal fusion surgery.

56 use of bone-morphogenetic proteins (BMPs) in spinal fusion surgery.

57 nstrated generally satisfactory results with spinal fusion surgery.

58 tive electrical stimulation as an adjunct to spinal fusion surgery.

59 an meet the stability criteria necessary for spinal fusion surgery.

60 e of pneumocephalus and pneumorrhachis after spinal fusion surgery.

61 counts of overuse in all services except for spinal fusion; the majority of major teaching hospitals

62 I spondylolisthesis, the addition of lumbar spinal fusion to laminectomy was associated with slightl

63 lar ejection fraction; interventions such as spinal fusion, tracheostomy, and noninvasive ventilation

64 An animal model of spinal fusion using osteoinductive growth factors has im

65 Complete spinal fusion was observed in 27.9% of patients with AS

66 of surgical-site infections (SSI) following spinal fusion was retrospectively studied.

67 BMP-2) is used as a bone graft substitute in spinal fusion, which unites (fuses) bones in the spine.

68 who fail conservative management may undergo spinal fusion with pedicle screw instrumentation.